Nen‐Chung Chang

2.0k citations
61 papers · 1.6k · 1 hit paper · h-index 21

Impact in

Papers in

    • Cardiac Fibrosis and Remodeling 8
    • Cardiovascular Function and Risk Factors 7
    • Renin-Angiotensin System Studies 5
    • Cardiac electrophysiology and arrhythmias 5
    • Blood Pressure and Hypertension Studies 5
    • Cardiomyopathy and Myosin Studies 4

Nen‐Chung Chang

57 papers receiving 1.6k citations

Nen‐Chung Chang's Hit Papers

Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts 2017 · 405 citations
4050+3+6Years since publication100200300400

Peers

Nen‐Chung Chang
Comparison fields: 5 of 110
  • Endocrinology, Diabetes and Metabolism 465
  • Cardiology and Cardiovascular Medicine 520
  • Nephrology 92
  • Surgery 423
  • Emergency Medicine 90
Replace Miyuki Kobara with:
Miyuki Kobara Japan
David Sanz‐Rosa Spain
Nirmal Parajuli Canada
Chiara Stranieri Italy
Masatsugu Hori Japan
Masayuki Kambe Japan
Angela Tesse France
Maike Knorr Germany
William G. McMaster United States
Ernesto Martínez‐Martínez Spain
Nen‐Chung Chang relative to Miyuki Kobara Japan Miyuki Kobara's profile →
Citations per field
00.5×
Miyuki Kobara · 1×
Citations per year

Countries citing papers authored by Nen‐Chung Chang

Since Specialization
Citations

This map shows the geographic impact of Nen‐Chung Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nen‐Chung Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nen‐Chung Chang more than expected).

Fields of papers citing papers by Nen‐Chung Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nen‐Chung Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nen‐Chung Chang. The network helps show where Nen‐Chung Chang may publish in the future.

Co-authors

The 25 scholars most cited alongside Nen‐Chung Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nen‐Chung Chang Line = papers co-authored together Nen‐Chung Chang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts
Hit paper breakdown →
2017405
2 201291
3 200876
4 201274
5 201072
6 201260
7 201456
8 201355
9 201154
10 200542
11 200440
12 200939
13 201135
14 200528
15 201427
16 201426
17 201424
18 202123
19 200421
20 201421

About Nen‐Chung Chang

Nen‐Chung Chang is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Physiology, Surgery and Endocrinology, Diabetes and Metabolism, having authored 61 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (11 papers), Cardiac Fibrosis and Remodeling (8 papers), Cardiovascular Function and Risk Factors (7 papers), Hormonal Regulation and Hypertension (6 papers), Renin-Angiotensin System Studies (5 papers), Cardiac electrophysiology and arrhythmias (5 papers), Blood Pressure and Hypertension Studies (5 papers) and Cardiomyopathy and Myosin Studies (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (465 citations), Cardiology and Cardiovascular Medicine (520 citations), Nephrology (92 citations), Surgery (423 citations) and Emergency Medicine (90 citations). Nen‐Chung Chang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Tsung‐Ming Lee, Shinn‐Zong Lin, Chun‐Yao Huang, Chun‐Ming Shih, Feng‐Yen Lin, Chien‐Chang Chen, Hsiu-Nien Shen, Shinn‐Zong Lin, Chien‐Chang Chen and Keng‐Liang Ou. Their work appears in journals such as PLoS ONE, American Journal of Physiology-Heart and Circulatory Physiology, Journal of Cellular and Molecular Medicine, Journal of Hypertension and Free Radical Biology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact